Treatment of Early Supraglottic Squamous Cell Carcinoma With Advance Technologies

计划入组 108 人 · 首次发布于 2022 年 11 月 10 日

Use of Phage Therapy for Treatment of a Periprosthetic Joint Infection

计划入组 1 人 · 首次发布于 2025 年 2 月 14 日

4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEF

计划入组 2,011 人 · 首次发布于 2014 年 4 月 15 日

Bone Marrow Aspirate Concentrate (BMAC) therapy(Cell Technologies)

NTCELL(Living Cell Technologies)

malaria vaccine, Artificial Cell Technologies

ON-X LIFE TECHNOLOGIES, INC.

United States

Stemedica Cell Technologies, Inc.

United States

Artificial Cell Technologies, Inc.

United States

Stem-cell therapies that work: 10 Breakthrough Technologies 2025

Xencor Reports Initial Phase 1 Results for XmAb819 ENPP3 x CD3 Bispecific in Clear Cell Renal Cell Carcinoma

X Cell–Derived Antibody Shows Potential to Reverse Type 1 Diabetes in Preclinical Models